Search company, investor...
Search
Envision Pharma company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

envisionpharmagroup.com

Founded Year

2001

Stage

Acq - Fin - III | Alive

About Envision Pharma

Envision Pharma is an international global technology and scientific communication company serving pharmaceutical, biotechnology, and medical device companies.

Envision Pharma Headquarters Location

Envision House, 5 North Street

West Sussex, England, RH12 1XQ,

United Kingdom

+44 (0) 1403 322 000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Envision Pharma Patents

Envision Pharma has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/11/2002

8/27/2013

Life sciences industry, Pharmaceutical industry, Dietary supplements, Food additives, Payment systems

Grant

Application Date

12/11/2002

Grant Date

8/27/2013

Title

Related Topics

Life sciences industry, Pharmaceutical industry, Dietary supplements, Food additives, Payment systems

Status

Grant

Latest Envision Pharma News

Envision Pharma Group partners with scite to display Smart Citations in iEnvision® – the global medical affairs platform

Jun 10, 2022

Search jobs 10-Jun-2022 Envision Pharma Group partners with scite to display Smart Citations in iEnvision® – the global medical affairs platform Envision Pharma Group partners with scite to display Smart Citations in iEnvision® – the global medical affairs platform Scientific Communication Platform modules   HORSHAM, UK, JUNE 9, 2022 – Technology-enabled scientific communications company Envision Pharma Group (“Envision” or the “Company”) today announced Library, Datavision, and Scientific Communication Platform (SCP) modules will now feature Smart Citations from scite, an award-winning tool that helps students and researchers discover and understand research findings better. Fully integrated into the publication details held within Library, Datavision, and SCP modules , Smart Citation badges provide regularly updated, at-a-glance views of how research has been cited and permits click-through access to the scite website for more detailed information on the article. This new functionality sits alongside and enhances the existing article-level metrics provided in iEnvision through integrations with Altmetric and Scopus. Russell Traynor, Envision’s Global Head, iEnvision Platform Strategy, and former chair of the International Society of Medical Publication Professionals, said, “We are excited to announce this collaboration and hope that the addition of Smart Citations to Library, Datavision, and SCP will provide additional insights and value to the users of our solutions.” Dr. Josh Nicholson, Chief Executive Officer of scite, added, “We’re very happy to be working with Envision to provide a powerful integration between the two platforms. Smart Citations are already used by various pharmaceutical companies and communications agencies and we’re happy to surface them in Library for a more streamlined workflow.” Editor Details PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2022.3.2.1 You are leaving PharmiWeb.com Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com. PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly. Continue

Envision Pharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Envision Pharma Rank

  • When was Envision Pharma founded?

    Envision Pharma was founded in 2001.

  • Where is Envision Pharma's headquarters?

    Envision Pharma's headquarters is located at Envision House, 5 North Street, West Sussex.

  • What is Envision Pharma's latest funding round?

    Envision Pharma's latest funding round is Acq - Fin - III.

  • Who are the investors of Envision Pharma?

    Investors of Envision Pharma include GHO Capital Partners, Ardian, The Halifax Group and United BioSource.

  • Who are Envision Pharma's competitors?

    Competitors of Envision Pharma include MedaSystems.

You May Also Like

myTomorrows Logo
myTomorrows

myTomorrows aims to change the way physicians and their patients access investigational drugs, rendering potentially life-saving drugs out of reach. myTomorrows offers a platform for doctors and patients seeking information on and access to investigational drugs, and drugs that have been approved by regulators in other countries. On the other side, myTomorrows offers drug developers a seamless turn-key solution for global early access programs to make their drugs accessible to those suffering from life threatening or debilitating diseases whilst gathering data.

CyberGrants Logo
CyberGrants

CyberGrants is a provider of software-as-a-service solutions for corporate social responsibility. Through its integrated grants management and employee engagement suite, CyberGrants connects companies, foundations, employees, and not-for-profits to support the delivery of charitable giving.

M
MedaSystems

MedaSystems is creating patient engagement and expanded access management software for biopharma companies.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.